NASDAQ Companies

ZILXI is the First FDA Approved Minocycline Product for the Treatment of Inflammatory Lesions of Rosacea in AdultsZILXI Offers Efficacy […]

BOSTON, Oct. 01, 2020 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential […]

STAMFORD, Conn., Oct. 01, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing […]

CAMBRIDGE, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives […]

Silence Therapeutics to Participate in the Chardan Virtual 4th Annual Genetic Medicines Conference1 October 2020LONDON, Silence Therapeutics plc (AIM: SLN) […]

Aurora, IL, Oct. 01, 2020 (GLOBE NEWSWIRE) — Cabot Microelectronics Corporation (Nasdaq: CCMP), a global supplier of consumable materials to […]

WALTHAM, Mass. and HALLE (Saale), Germany, Oct. 01, 2020 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused […]

CAESAREA, Israel, Oct. 01, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and […]

NEW YORK, Oct. 01, 2020 (GLOBE NEWSWIRE) — ExlService Holdings, Inc. (“EXL”) (NASDAQ: EXLS), a leading operations management and analytics […]

Nes Ziona, Israel, Oct. 01, 2020 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company, […]